QQ客服 官方微博 反馈留言

	Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease
	Jiang, Nan; Du, Sichen; Ou, Huayuan; Cui, Renjie; Zhang, Meiqin; Li, Xiaorong; Ma, Jing; Zhang, Jin; Ma, Duan
刊名	HUMAN GENE THERAPY
	2019
卷号	30期号:2
关键词	Gaucher disease gene therapy AAV9 GD mouse model
ISSN号	1043-0342
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3595053
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Jiang, Nan,Du, Sichen,Ou, Huayuan,et al. Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease[J]. HUMAN GENE THERAPY,2019,30(2).
APA	Jiang, Nan.,Du, Sichen.,Ou, Huayuan.,Cui, Renjie.,Zhang, Meiqin.,...&Ma, Duan.(2019).Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease.HUMAN GENE THERAPY,30(2).
MLA	Jiang, Nan,et al."Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease".HUMAN GENE THERAPY 30.2(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。